Dectrekumab (Anti-IL-13)
Dectrekumab (anti-IL-13) is a humanized monoclonal antibody that targets interleukin-13 (IL-13). It has the potential to be used in inflammation and immunology-related research. MW: 146.16 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2950 |
| Sku # | A2950-1mg*25 |
| Pricing | 1mg*25, $5070.00 |